Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging.

BMC Cancer · 2015 · PMC4647606 · PMID 26573613

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

borderline significantP = 0.053so close (0.05 < p ≤ 0.1)

This difference was borderline significant when the absolute values of K trans were considered ( P = 0.053) and significant when the K trans values were normalized to the pretreatment values ( P = 0.032).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.